Ashland Inc. (ASH) stock
ASHNYSEWholesale-Chemicals & Allied ProductsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026Score 6/3025% above fair value
$75.27−1.45 (-1.89%)
Close on Nov 12, 2026Market cap $3.45BP/E –Yield 2.18%
Ashland ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Ashland's ebitda for the twelve months ending Jun 30, 2026 was $328.00M. For fiscal 2025 it was -$538.00M, down 316.9% from the year before. The highest annual figure on record is $574.00M in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$538.00M | -316.9% |
| FY2024 | Sep 30, 2024 | $248.00M | -40.2% |
| FY2023 | Sep 30, 2023 | $415.00M | -27.7% |
| FY2022 | Sep 30, 2022 | $574.00M | +31.7% |
| FY2021 | Sep 30, 2021 | $436.00M | – |
| FY2020 | Sep 30, 2020 | -$226.00M | -162.3% |
| FY2019 | Sep 30, 2019 | $363.00M | -4.2% |
| FY2018 | Sep 30, 2018 | $379.00M | +20.7% |
| FY2017 | Sep 30, 2017 | $314.00M | +24.6% |
| FY2016 | Sep 30, 2016 | $252.00M | -39.7% |
| FY2015 | Sep 30, 2015 | $418.00M | -4.8% |
| FY2014 | Sep 30, 2014 | $439.00M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $91.00M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $84.00M | -24.3% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | $42.00M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $111.00M | +32.1% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$632.00M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $111.00M | +6.7% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$128.00M | -316.9% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $84.00M | +61.5% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $0 | -100.0% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $104.00M | -27.8% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $59.00M | -38.5% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $52.00M | -62.3% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $123.00M | -28.9% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $144.00M | -10.6% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $96.00M | -5.9% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $138.00M | -4.8% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $173.00M | +61.7% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $161.00M | +50.5% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $102.00M | +34.2% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $145.00M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $107.00M | -1.8% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $107.00M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $76.00M | -2.6% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$6.00M | -110.3% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $109.00M | +3.8% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$407.00M | -423.0% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $78.00M | +5.4% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $58.00M | -19.4% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $105.00M | +8.2% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $126.00M | -6.7% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $74.00M | -1.3% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $72.00M | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $97.00M | -19.8% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $135.00M | +13.4% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $75.00M | -9.6% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$9.00M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $121.00M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $119.00M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $83.00M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$119.00M | – |
See a number that looks wrong?